Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131949) titled 'Reduced-Dose Bivalirudin Anticoagulation Study in PCI' on Sept. 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Hospital of China Medical University
Condition:
Coronary Atherosclerotic Heart Disease
Intervention:
Control Group:Standard-Dose Bivalirudin Anticoagulation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-20
Target Sample Size: Control Group:125;Experimental group:125;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335479
Published by HT Digital Content Services with...